<qa>  What is the name of the CANCER that is a RECOMBINANT MERECOMBINANT MEASLES VIRUS VACCINE THERAPY AND ONCOLYTIC VIRUS THERAPY IN TREATING PATIENTS WITH PROGRESSIVE, RECURRENT, OR REFRACTORY OVARIAN EPITHELIAL CANCER OR PRIMARY PERITONEAL CANCER: 